131 related articles for article (PubMed ID: 10086813)
21. Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses.
Reicher S; Boyar FZ; Albitar M; Sulcova V; Agersborg S; Nga V; Zhou Y; Li G; Venegas R; French SW; Chung DS; Stabile BE; Eysselein VE; Anguiano A
Pancreas; 2011 Oct; 40(7):1057-62. PubMed ID: 21705950
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic ultrasound fine needle aspirate DNA analysis to differentiate malignant and benign pancreatic masses.
Khalid A; Nodit L; Zahid M; Bauer K; Brody D; Finkelstein SD; McGrath KM
Am J Gastroenterol; 2006 Nov; 101(11):2493-500. PubMed ID: 17029619
[TBL] [Abstract][Full Text] [Related]
23. Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups.
Yan L; McFaul C; Howes N; Leslie J; Lancaster G; Wong T; Threadgold J; Evans J; Gilmore I; Smart H; Lombard M; Neoptolemos J; Greenhalf W
Gastroenterology; 2005 Jun; 128(7):2124-30. PubMed ID: 15940643
[TBL] [Abstract][Full Text] [Related]
24. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
[TBL] [Abstract][Full Text] [Related]
25. [The incidence, clinical and biologic diagnosis, and prognosis of cancer of the exocrine pancreas and biliary tract].
Gainant A; Cubertafond P
Rev Prat; 1989 Oct; 39(22):1933-7. PubMed ID: 2814274
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.
Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A
PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130
[TBL] [Abstract][Full Text] [Related]
27. Detection of K-ras point mutation at codon 12 in pancreatic diseases: a study in a Brazilian casuistic.
Kubrusly MS; Cunha JE; Bacchella T; Abdo EE; Jukemura J; Penteado S; Morioka CY; de Souza LJ; Machado MC
JOP; 2002 Sep; 3(5):144-51. PubMed ID: 12221329
[TBL] [Abstract][Full Text] [Related]
28. Carcinoembryonic antigen in the bile in patients with pancreatic and biliary cancer. Correlation with cytology and percutaneous transhepatic cholangiography.
Tatsuta M; Yamamura H; Yamamoto R; Morii T; Okuda S; Tamura H
Cancer; 1982 Dec; 50(12):2903-9. PubMed ID: 7139579
[TBL] [Abstract][Full Text] [Related]
29. K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China.
Rashid A; Ueki T; Gao YT; Houlihan PS; Wallace C; Wang BS; Shen MC; Deng J; Hsing AW
Clin Cancer Res; 2002 Oct; 8(10):3156-63. PubMed ID: 12374683
[TBL] [Abstract][Full Text] [Related]
30. [Computerized methods in the diagnosis and prognosis of surgically treated bilio-pancreatic diseases].
Festa T; Foco A; Serenthà U; Enrichens F; Sciascia C; Caponi R; Manconi P; Grande L; Vogliolo B; Cardone M; Fornero G; Barberio V; Giordano A; Curti B; Pasquino M
Minerva Med; 1983 Feb; 74(7):289-300. PubMed ID: 6338420
[TBL] [Abstract][Full Text] [Related]
31. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.
Tada M; Omata M; Ohto M
Gastroenterology; 1991 Jan; 100(1):233-8. PubMed ID: 1983826
[TBL] [Abstract][Full Text] [Related]
32. KRAS mutation testing on all non-malignant diagnosis of pancreatic endoscopic ultrasound-guided fine-needle aspiration biopsies improves diagnostic accuracy.
Trisolini E; Armellini E; Paganotti A; Veggiani C; Bozzola C; Frattini M; Pizio C; Mancuso G; Andorno S; Boldorini R
Pathology; 2017 Jun; 49(4):379-386. PubMed ID: 28450086
[TBL] [Abstract][Full Text] [Related]
33. Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product.
van Es JM; Polak MM; van den Berg FM; Ramsoekh TB; Craanen ME; Hruban RH; Offerhaus GJ
J Clin Pathol; 1995 Mar; 48(3):218-22. PubMed ID: 7730480
[TBL] [Abstract][Full Text] [Related]
34. How useful is it clinically to analyse the K-ras mutational status for the diagnosis of exocrine pancreatic cancer? A systematic review and meta-analysis.
Parker LA; Lumbreras B; Lopez T; Hernández-Aguado I; Porta M
Eur J Clin Invest; 2011 Jul; 41(7):793-805. PubMed ID: 21391995
[TBL] [Abstract][Full Text] [Related]
35. Generalizing molecular results arising from incomplete biological samples: expected bias and unexpected findings.
Porta M; Malats N; Corominas JM; Rifà J; Piñol JL; Real FX;
Ann Epidemiol; 2002 Jan; 12(1):7-14. PubMed ID: 11750234
[TBL] [Abstract][Full Text] [Related]
36. CA 19-9 and CA 50 in benign and malignant pancreatic and biliary diseases.
Paganuzzi M; Onetto M; Marroni P; Barone D; Conio M; Aste H; Pugliese V
Cancer; 1988 May; 61(10):2100-8. PubMed ID: 2834038
[TBL] [Abstract][Full Text] [Related]
37. Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma.
Henriksen SD; Madsen PH; Larsen AC; Johansen MB; Drewes AM; Pedersen IS; Krarup H; Thorlacius-Ussing O
Clin Epigenetics; 2016; 8():117. PubMed ID: 27891190
[TBL] [Abstract][Full Text] [Related]
38. Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses.
Ogura T; Yamao K; Sawaki A; Mizuno N; Hara K; Hijioka S; Niwa Y; Tajika M; Kondo S; Shimizu Y; Bhatia V; Higuchi K; Hosoda W; Yatabe Y
Gastrointest Endosc; 2012 Apr; 75(4):769-74. PubMed ID: 22284089
[TBL] [Abstract][Full Text] [Related]
39. The pancreas.
Laugier R; Sarles H
Clin Gastroenterol; 1985 Oct; 14(4):749-56. PubMed ID: 2417759
[No Abstract] [Full Text] [Related]
40. Quantitative analysis of ras gene mutation in pancreatic juice for diagnosis of pancreatic adenocarcinoma.
Tada M; Teratani T; Komatsu Y; Kawabe T; Shiratori Y; Omata M
Dig Dis Sci; 1998 Jan; 43(1):15-20. PubMed ID: 9508517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
